GlassScriptPhysician profile
Jaime Davis Byrum
NPI 1740362037
$3,080.66
in general payments reported to CMS, 2019-2025
19 companies · $387 in 2025
The $387 reported for 2025 was more than what 89% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $622 · 2022: $845 · 2023: $698 · 2024: $529 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $837.79 | 2021-2025 | |
| Gilead Sciences, INC. | $812.76 | 2021-2025 | |
| Alkermes, INC. | $550.71 | 2021-2023 | Vivitrol, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $272.88 | 2022-2025 | Caplyta |
| Pfizer INC. | $132.34 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $109.76 | 2022 | |
| Indivior INC. | $74.73 | 2021-2024 | Sublocade |
| Novo Nordisk INC | $45.59 | 2022-2025 | |
| Radius Health, INC. | $36.53 | 2022 | |
| Merck Sharp & Dohme LLC | $36.19 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Axsome Therapeutics, INC. | $26.45 | 2025 | Auvelity |
| Ars Pharmaceuticals Operations, INC. | $25.92 | 2025 | Neffy |
| Mylan Specialty L.P. | $24.19 | 2021 | |
| Corium, LLC | $22.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $15.83 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.23 | 2021 | |
| Medtronic, INC. | $13.60 | 2021 | |
| Cequr Corporation | $9.89 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Byrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.